Drug points: Withdrawal reaction associated with venlafaxine

Nottingham Healthcare NHS Trust, Wells Road Centre, Nottingham NG3 3AA.
BMJ Clinical Research (Impact Factor: 14.09). 10/1998; 317(7161):787. DOI: 10.1136/bmj.317.7161.787a
Source: PubMed
Download full-text


Available from: Walter P Bouman, Oct 02, 2015
22 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report a patient who developed discontinuation symptoms following nefazodone cessation. The patient experienced nausea, vomiting, diarrhoea, ataxia, insomnia, marked agitation, headache and flu-like symptoms. She was reluctant to recommence nefazodone and was symptomatically treated with oxazepam. The patient recovered completely in 10 days. Nefazodone discontinuation can result in withdrawal symptoms and therefore needs to be tapered gradually. Those who have experienced discontinuation symptoms with other antidepressants in the past may be at increased risk.
    Australian and New Zealand Journal of Psychiatry 09/1999; 33(4):594-7. DOI:10.1046/j.1440-1614.1999.00567.x · 3.41 Impact Factor
  • Clinical pharmacy 01/2000; 1(5):462-3. DOI:10.1016/S0733-8627(05)70151-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Venlafaxine is an antidepressant that selectively inhibits serotonin reuptake and is a norepinephrine inhibitor. Withdrawal syndromes can occur after abrupt drug discontinuation of long-term regimens. Exegesis We report six cases of withdrawal symptoms after venlafaxine discontinuation. Conclusion Physicians must be aware of the frequency, rapidity and potent severity of these withdrawal syndromes.
    La Revue de Médecine Interne 03/2000; 21(3):282-284. DOI:10.1016/S0248-8663(00)80048-X · 1.07 Impact Factor
Show more